Implications of the Genetic Epidemiology of Globin Haplotypes Linked to the Sickle Cell Gene in Southern Iran

ABSTRACT To determine the origin of sickle cell mutation in different ethnic groups living in southern Iran, we studied the haplotype background of the βS and βA genes in subjects from the provinces of Fars, Khuzestan, Bushehr, Hormozgan, and Kerman and from the islands of Khark and Qeshm. β-globin gene cluster haplotypes were determined using the PCR-RFLP technique. Detection of −α3.7 deletion and β-thalassemia mutations were defined by PCR and reverse dot blot techniques, respectively. The framework of the β-globin gene was determined using denaturing gradient gel electrophoresis. We found that the βS mutation in southern Iran is associated with multiple mutational events. Most of the patients were from two ethnic groups: Farsi speakers (presumably Persian in origin) from Fars province and patients of Arab origin from Khuzestan province. In both ethnic groups the Arab-Indian haplotype was the most prevalent. The frequencies of the Arab-Indian and African haplotypes in sickle cell anemia patients from the provinces of Fars and Khuzestan were similar. Among βA chromosomes the Bantu A2 haplotype was the most prevalent. The decrease in α-globin production in SS patients and AS individuals appeared to be related to the reduction in mean cell volume and mean cell hemoglobin. The Arab-Indian haplotype gene flow into this region of Iran can be traced to the Sassanian Empire. It is likely that the influx of βS genes linked to the Benin and Bantu haplotypes, of African origin, must have occurred during the Arab slave trade.

[1]  Z. Rahimi,et al.  The β-GLobin Gene Haplotypes Associated With Hb D-Los Angeles [β121(GH4)Glu→Gln] in Western Iran , 2006 .

[2]  Z. Rahimi,et al.  The beta-globin gene haplotypes associated with Hb D-Los Angeles [beta121(GH4)Glu --> Gln] in Western Iran. , 2006, Hemoglobin.

[3]  Z. Rahimi,et al.  β‐Globin gene cluster haplotypes in sickle cell patients from southwest Iran , 2003, American journal of hematology.

[4]  K. Kahrizi,et al.  High Prevalence of the −α3.7 Deletion Among Thalassemia Patients in Iran , 2003 .

[5]  R. Nagel,et al.  Genetic epidemiology of HbS in Oman: Multicentric origin for the βS gene , 2000 .

[6]  J. Krieger,et al.  Atypical βs haplotypes are generated by diverse genetic mechanisms , 2000 .

[7]  F. Galactéros,et al.  α-Thalassemia in Bantu Population from Congo-Brazzaville: Its Interaction with Sickle Cell Anemia , 1999, Human Heredity.

[8]  Y. Niranjan,et al.  Some atypical and rare sickle cell gene haplotypes in populations of Andhra Pradesh, India. , 1999, Human biology.

[9]  G. Stamatoyannopoulos,et al.  Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. , 1998, Blood.

[10]  E. Bakker Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases , 1997 .

[11]  R. Nagel,et al.  Effect of α‐thalassemia on sickle‐cell anemia linked to the Arab‐Indian haplotype in India , 1997 .

[12]  A. Adekile Historical and anthropological correlates of beta S haplotypes and alpha- and beta-thalassemia alleles in the Arabian Peninsula. , 1997, Hemoglobin.

[13]  A. Adekile,et al.  Morbidity, βs Haplotype and α-Globin Gene Patterns among Sickle Cell Anemia Patients in Kuwait , 1996 .

[14]  E. Baysal,et al.  Detection of common deletional α‐thalassemia‐2 determinants by PCR , 1994 .

[15]  J. Wall,et al.  Reverse dot blot probes for the screening of β‐thalassernia mutationsin Asians and American blacks , 1994 .

[16]  M. Vidaud,et al.  A comprehensive scanning method for rapid detection of β‐globin gene mutations and polymorphisms , 1992, Human mutation.

[17]  A. al-Azmeh Race and slavery in the Middle East: an historical enquiry , 1991 .

[18]  A. Kulozik,et al.  Two different forms of homozygous sickle cell disease occur in Saudi Arabia , 1991, British journal of haematology.

[19]  R. Nagel,et al.  The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. , 1991, Blood.

[20]  B. Lewis Race and slavery in the Middle East : an historical enquiry , 1991 .

[21]  D. Labie,et al.  Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. , 1989, Human biology.

[22]  D. Weatherall,et al.  The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene , 1988 .

[23]  D. Weatherall,et al.  The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene. , 1988, Blood.

[24]  T. Huisman High-performance liquid chromatography as a method to identify haemoglobin abnormalities. , 1987, Acta haematologica.

[25]  D. Weatherall,et al.  Fetal hemoglobin levels and beta (s) globin haplotypes in an Indian populations with sickle cell disease. , 1987, Blood.

[26]  D. Labie,et al.  The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. , 1987, Blood.

[27]  A. Kulozik,et al.  Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. , 1986, American journal of human genetics.

[28]  D. Labie,et al.  Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. , 1985, The New England journal of medicine.

[29]  D. Labie,et al.  Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Orkin,et al.  Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster , 1982, Nature.

[31]  T. Maniatis,et al.  The nucleotide sequence of the human β-globin gene , 1980, Cell.

[32]  F. Ismail-Beigi,et al.  Mild sickle-cell anaemia in Iran associated with high levels of fetal haemoglobin. , 1977, Journal of medical genetics.

[33]  R. Schneider Differentiation of electrophoretically similar hemoglobins--such as S, D, G, and P; or A2, C, E, and O--by electrophoresis of the globin chains. , 1974, Clinical chemistry.